Skip to content

Combined effect of dexamethasone, hyoscine and misoprostol drugs during therapeutic or legal abortion in patients visiting Imam Khomeini Hospital in Tehran

Combined effect of dexamethasone, hyoscine and misoprostol drugs during therapeutic or legal abortion in patients visiting Imam Khomeini Hospital in Tehran

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180409039247N9
Enrollment
75
Registered
2024-01-04
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion. Missed abortion

Interventions

Intervention 1: Intervention group: Vaginal misoprostol 400 micro every 4 hours until abortion. Intervention 2: Intervention group: Vaginal misoprostol 400 micrograms every 4 hours + dexamethasone 8 m

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 45 Years

Inclusion criteria

Inclusion criteria: pregnant woman aged 25-45 who has become pregnant spontaneously and the necessity of performing a therapeutic or legal abortion has been definitively diagnosed. Patient's awareness and acceptance of two medical and surgical methods and complications resulting from each of them Intrauterine pregnancy with a gestational age of 14 weeks or less based on ultrasound or the date of the last menstrual period a reason to terminate the pregnancy (missed abortion, blighted ovum, therapeutic abortion)

Exclusion criteria

Exclusion criteria: Allergy to Drug IUD (intrauterine device) severe anemia coagulation disorder or use of anticoagulants uncontrolled seizures adrenal disease with high blood pressure cardiovascular disease active liver disease use Steroid drugs

Design outcomes

Primary

MeasureTime frame
Comparison of intervention in the amount of patient pain during abortion, comparison of intervention in the amount of patient bleeding during abortion, comparison of intervention in the time required for abortion. Timepoint: The amount of bleeding and the time required are measured at the end of the process. Method of measurement: The amount of bleeding is measured based on the patient's pads and the time is measured based on hours and minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarjan Ghaemibidgoli

Tehran University of Medical Sciences

marjan_ghaemi@yahoo.com+98 21 8800 4858

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026